Page last updated: 2024-10-31

n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Degenerative Diseases, Central Nervous System

n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide: thrombin inhibitor; RN given refers to parent cpd without isomeric designation

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carreño-Müller, E1
Herrera, AJ1
de Pablos, RM1
Tomás-Camardiel, M1
Venero, JL1
Cano, J1
Machado, A1

Other Studies

1 other study available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Degenerative Diseases, Central Nervous System

ArticleYear
Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia.
    Journal of neurochemistry, 2003, Volume: 84, Issue:5

    Topics: Animals; Antithrombins; Corpus Striatum; Dipeptides; Dopamine; Dose-Response Relationship, Drug; Enz

2003